About Ken Herrmann
Ken Herrmann is a director at Aktis Oncology.
Ken Herrmann reports to the SEC as a director of 1 public company.
Ken Herrmann first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Ken Herrmann in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ken Herrmann works with at each company, as listed on that company's latest Form D.
Aktis Oncology, Inc. · Form D, Oct 2, 2024
HK
Helen Kim
Director
SB
Shulamit Ron-Bigger
Executive officer
LS
Lloyd Segal
Director
ON
Oleg Nodelman
Director
AL
Andrew Levin
Director
MR
Matthew Roden
CEO and director
TF
Todd Foley
Director